NDT Advance Access originally published online on January 5, 2006
Nephrology Dialysis Transplantation 2006 21(5):1417-1419; doi:10.1093/ndt/gfk046
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author [2006]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Case Report
Status epilepticus and hyperprolinaemia following recurrent gelatine administrations in a patient on peritoneal dialysis
Department of Paediatrics, Medical School Hanover, Germany
Correspondence and offprint requests to: A. M. Das, MD, PhD, Department of Paediatrics, Medical School Hanover, Carl-Neuberg Str. 1, D-30623 Hanover, Germany. Email: Das.Anibh@mh-hannover.de
Keywords: epilepsy; gelatine infusion; hyperprolinaemia; peritoneal dialysis; proline; renal insufficiency
| The first 10% of the full text of this article appears below. |
| Introduction |
|---|
Gelatine is commonly used as a colloid volume expander in hypovolaemic shock. Up to 22% of its amino acids are proline and hydroxyproline. Accumulation of proline in patients on dialysis receiving gelatine infusions has not been described before.
We report a patient on peritoneal dialysis who developed epileptic seizures after recurrent gelatine administration leading to hyperprolinaemia.
| Case |
|---|
We report a 19-year-old woman undergoing peritoneal dialysis for the treatment of end-stage renal failure due to congenital kidney dysplasia. She was also suffering from psychomotor retardation and congestive cardiomyopathy. Her serum lactate ranged between 3 and 4.5 mM, a possible clue to mitochondrial dysfunction. Previous investigations had failed to prove a
| Discussion |
|---|
Conclusion